Acta Materialia, Acta Biomaterialia, Scripta Materialia, Materialia Journals

Dr. Feinberg is the principal investigator of the Regenerative Biomaterials and Therapeutics Group and a Professor at Carnegie Mellon University. He earned his BS in Materials Science and Engineering from Cornell University in 1999 with Co-op experience at Abiomed, Inc., working on total artificial hearts. He then earned his PhD in Biomedical Engineering from the University of Florida, focused on engineering cell-material interactions to prevent and enhance adhesion. This was followed by postdoctoral training at Harvard University, developing new biomaterials and stem cell-based cardiac tissue engineering strategies. He joined the faculty at Carnegie Mellon in the fall of 2010 with joint appointments in Biomedical Engineering and Materials Science and Engineering. Dr. Feinberg has co-authored over 100 peer-reviewed publications, holds over 30 US patents and patent applications and is Co-Founder and CTO of FluidForm Bio, Inc., a start-up company commercializing FRESH 3D bioprinting technology. He has also been awarded the NSF CAREER Award and the NIH Director’s New Innovator Award, and is a Fellow of the American Institute for Medical And Biological Engineering (AIMBE). Current research is focused on extracellular matrix (ECM) protein scaffolds engineered using advanced nanofabrication and 3D bioprinting approaches for a wide range of applications including breast cancer, cornea, skeletal muscle and cardiac muscle tissue engineering. Key to this is identifying engineering design principles from developmental biology and applying these to build therapeutic-scale human tissues, with a focus on manufacturability and scalability to support future clinical translation.